124 related articles for article (PubMed ID: 11249637)
21. Generation of carrier peptides for the delivery of nucleic acid drugs in primary cells.
Rennert R; Neundorf I; Jahnke HG; Suchowerskyj P; Dournaud P; Robitzki A; Beck-Sickinger AG
ChemMedChem; 2008 Feb; 3(2):241-53. PubMed ID: 18205166
[TBL] [Abstract][Full Text] [Related]
22. Cellular uptake [correction of utake] of the Tat peptide: an endocytosis mechanism following ionic interactions.
Vives E
J Mol Recognit; 2003; 16(5):265-71. PubMed ID: 14523939
[TBL] [Abstract][Full Text] [Related]
23. Exploration of peptide motifs for potent non-viral gene delivery highly selective for dividing cells.
Parker AL; Collins L; Zhang X; Fabre JW
J Gene Med; 2005 Dec; 7(12):1545-54. PubMed ID: 16037993
[TBL] [Abstract][Full Text] [Related]
24. Low molecular weight protamine as an efficient and nontoxic gene carrier: in vitro study.
Park YJ; Liang JF; Ko KS; Kim SW; Yang VC
J Gene Med; 2003 Aug; 5(8):700-11. PubMed ID: 12898639
[TBL] [Abstract][Full Text] [Related]
25. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer.
Wadia JS; Dowdy SF
Adv Drug Deliv Rev; 2005 Feb; 57(4):579-96. PubMed ID: 15722165
[TBL] [Abstract][Full Text] [Related]
26. Self-assembled ternary complexes of plasmid DNA, low molecular weight polyethylenimine and targeting peptide for nonviral gene delivery into neurons.
Zeng J; Wang X; Wang S
Biomaterials; 2007 Mar; 28(7):1443-51. PubMed ID: 17156837
[TBL] [Abstract][Full Text] [Related]
27. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
Deshayes S; Morris M; Heitz F; Divita G
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):537-47. PubMed ID: 18037526
[TBL] [Abstract][Full Text] [Related]
28. Polycation gene delivery systems: escape from endosomes to cytosol.
Cho YW; Kim JD; Park K
J Pharm Pharmacol; 2003 Jun; 55(6):721-34. PubMed ID: 12841931
[TBL] [Abstract][Full Text] [Related]
29. [PNA--peptide nucleic acids. Towards gene therapeutic drugs].
Nielsen PE
Ugeskr Laeger; 1998 Aug; 160(36):5171-4. PubMed ID: 9741271
[TBL] [Abstract][Full Text] [Related]
30. A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells.
Albarran B; To R; Stayton PS
Protein Eng Des Sel; 2005 Mar; 18(3):147-52. PubMed ID: 15820981
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial drug delivery and mitochondrial disease therapy--an approach to liposome-based delivery targeted to mitochondria.
Yamada Y; Akita H; Kogure K; Kamiya H; Harashima H
Mitochondrion; 2007; 7(1-2):63-71. PubMed ID: 17296332
[TBL] [Abstract][Full Text] [Related]
32. Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos.
Chugh A; Eudes F
FEBS J; 2008 May; 275(10):2403-14. PubMed ID: 18397318
[TBL] [Abstract][Full Text] [Related]
33. Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic tat and oligoarginine peptides.
Shiraishi T; Pankratova S; Nielsen PE
Chem Biol; 2005 Aug; 12(8):923-9. PubMed ID: 16125104
[TBL] [Abstract][Full Text] [Related]
34. TAT transduction: the molecular mechanism and therapeutic prospects.
Gump JM; Dowdy SF
Trends Mol Med; 2007 Oct; 13(10):443-8. PubMed ID: 17913584
[TBL] [Abstract][Full Text] [Related]
35. Peptide-based gene delivery.
Mahat RI; Monera OD; Smith LC; Rolland A
Curr Opin Mol Ther; 1999 Apr; 1(2):226-43. PubMed ID: 11715946
[TBL] [Abstract][Full Text] [Related]
36. Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivo.
Henke E; Perk J; Vider J; de Candia P; Chin Y; Solit DB; Ponomarev V; Cartegni L; Manova K; Rosen N; Benezra R
Nat Biotechnol; 2008 Jan; 26(1):91-100. PubMed ID: 18176556
[TBL] [Abstract][Full Text] [Related]
37. VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection.
Sheridan PJ; Lawrie A; Crossman DC; Holt CM; Newman CM
J Gene Med; 2005 Mar; 7(3):375-85. PubMed ID: 15543525
[TBL] [Abstract][Full Text] [Related]
38. Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.
Moulton HM; Nelson MH; Hatlevig SA; Reddy MT; Iversen PL
Bioconjug Chem; 2004; 15(2):290-9. PubMed ID: 15025524
[TBL] [Abstract][Full Text] [Related]
39. Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery.
Mäe M; Langel U
Curr Opin Pharmacol; 2006 Oct; 6(5):509-14. PubMed ID: 16860608
[TBL] [Abstract][Full Text] [Related]
40. Electrically assisted ocular gene therapy.
Bejjani RA; Andrieu C; Bloquel C; Berdugo M; BenEzra D; Behar-Cohen F
Surv Ophthalmol; 2007; 52(2):196-208. PubMed ID: 17355857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
